(Q42493528)

1 November 2017

Vascular proliferation is increased in basal-like breast cancer (English)

1 reference

1 November 2017

William David Foulkes

series ordinal

5

1 reference

1 November 2017

6

Lars A Akslen

1 reference

1 November 2017

1

Hawa Nalwoga

1 reference

1 November 2017

3

Ingunn M Stefansson

1 reference

1 November 2017

Jarle B Arnes

2

1 reference

1 November 2017

Henry Wabinga

series ordinal

4

1 reference

1 November 2017

language of work or name

English

0 references

publication date

28 August 2011

1 reference

Breast Cancer Research and Treatment

1 November 2017

1 reference

1 November 2017

130

1 reference

1 November 2017

1063-1071

1 reference

1 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1740-7

1 November 2017

0 references

cites work

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Basal-like breast cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Breast cancers with brain metastases are more likely to be estrogen receptor negative, express the basal cytokeratin CK5/6, and overexpress HER2 or EGFR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Breast tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Vascular endothelial growth factor expression in the basal subtype of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Expression of EGFR and c-kit is associated with the basal-like phenotype in breast carcinomas of African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Molecular subtypes of breast cancers detected in mammography screening and outside of screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Differences in risk factors for breast cancer molecular subtypes in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

A compact VEGF signature associated with distant metastases and poor outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

EGFR associated expression profiles vary with breast tumor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

Antiangiogenic strategies, compounds, and early clinical results in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1740-7

10.1007/S10549-011-1740-7

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference